From the WAVES Growth OS

D3 helps founder-led life sciences, pharma, and med device companies grow.

If you’re building a $1M–$50M founder-led B2B company in life sciences, SaaS, software, pharmaceutical, or medical device and you’re ready for an operating layer that compounds, we’d love to talk. See how WAVES works →  |  Take the WAVES Kompass

Send us a text

In this episode of the Life Science Success Podcast my guest is John Schmitt, a military veteran, entrepreneur, and Co-Founder & CEO of iXpressGenes who is leveraging innovative RNA biomarker technologies to revolutionize trauma screening in healthcare. With over 20 years of leadership experience in the U.S. Army and a Master's degree in Microbiology and Immunology, John is dedicated to developing data-driven solutions for early detection and prevention of trauma-related diseases.

00:00 Introduction and Podcast Overview
01:02 Welcoming the Guest: John Schmitt
02:00 John Schmitt's Journey to Biotechnology
05:58 Military Experience and Leadership Insights
13:09 Founding  iXpressGenes: The Origin Story
17:31 Mission and Objectives of iXpressGenes
23:08 Challenges and Innovations in Biomarker Technologies
27:42 Personal Leadership and Inspirations
35:00 Conclusion and Podcast Wrap-Up